Outrun Therapeutics

Outrun Therapeutics develops E3 ligase inhibitors to stabilize proteins and treat diseases like cancer and neurology. Their proprietary platform enables rapid assessment of E3 ligase targets, accelerating drug discovery. This approach aims to restore the body's natural disease suppression processes by targeting the protein degradation mechanism.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $10M

Date: 18-Apr-2024

Investors: M Ventures, MP Healthcare Venture Management

Markets: Biotechnology, Oncology, Neurology

HQ: Dundee, Scotland, United Kingdom

Founded: 2019

Website: https://outruntx.com/

LinkedIn: https://www.linkedin.com/company/outrun-therapeutics

Twitter:

Instagram: